A Phase I Investigation of the Safety, Tolerability and Immunological Effects of T Lymphocytes Transduced With an Anti-Lewis Y (LeY) Chimeric Antigen Receptor Gene (LeY CAR T) in Patients With LeY Antigen Expressing Advanced Solid Tumours
Latest Information Update: 04 May 2021
At a glance
- Drugs Anti-Lewis-Y transduced T cells (Primary) ; Fludarabine; Loratadine; Paracetamol; Promethazine; Promethazine
- Indications Solid tumours
- Focus Adverse reactions; First in man
- 03 May 2021 Status changed from recruiting to active, no longer recruiting.
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology
- 20 Feb 2019 Planned number of patients changed from 30 to 24.